News

GHK-Cu to Counteract Bone-Loss Skin Changes After GLP-1 Weight Loss
Rapid weight loss from GLP-1 agonists can reveal bone-loss skin changes. GHK-Cu may support collagen and bone density to counteract facial hollowing Read more...
GHK-Cu vs. Argireline for GLP-1 Rapid Weight-Loss Skin
Rapid weight loss from GLP-1 agonists can leave loose, wrinkled skin. This article compares GHK-Cu and Argireline peptides, examining published Read more...
GHK-Cu for Bone-Loss Skin Laxity During Menopause and GLP-1
Menopause and GLP-1 weight loss both accelerate skin laxity and bone changes. Research on GHK-Cu suggests the tripeptide may support collagen synthesis and tissue repair. Read more...
GHK-Cu vs. Argireline for Fracture-Related Skin Atrophy
GHK-Cu and Argireline differ in mechanism and evidence base for skin integrity during semaglutide-driven weight loss. This comparison maps the research on collagen synthesis, dermal density, and structural support. Read more...
GHK-Cu Post-Weight-Loss Skin Tightening After GLP-1 Therapy
GHK-Cu demonstrates superior skin remodeling over retinol in post-weight-loss laxity, with clinical trials showing nearly threefold greater elasticity gains and fewer adverse effects. Read more...
Argireline for Expression Lines During Weight Loss
Argireline reduces neuromuscular activity at expression sites, potentially preserving dermal integrity when subcutaneous fat loss unmasks repetitive folding during weight change. Read more...
GHK-Cu pour prévenir la perte de tissu cutané durant un protocole de perte de poids
Le GHK-Cu et l'Argireline agissent par des voies distinctes pour préserver la qualité cutanée durant la perte de poids, l'un stimulant la synthèse matricielle, l'autre modulant la contraction musculaire. Read more...